E M Cross1, D J Hare. 1. Department of Clinical Psychology, University of Manchester, Manchester, UK. elaine.cross@nhs.net
Abstract
BACKGROUND: The mucopolysaccharide disorders (MPS) are a group of recessively inherited metabolic disorders resulting in progressive physical and cognitive decline. MATERIALS AND METHODS: MEDLINE, PsycINFO and Embase databases were searched, alongside manual screening, to identify relevant literature. Papers were included in the review if they were published in a peer reviewed journal and conducted empirical research into cognitive, motor, social or linguistic development or behaviour in one or more MPS disorders. RESULTS: Twenty-five papers were reviewed. Two papers used methodology of a sufficiently high standard to demonstrate a behavioural phenotype; both found sleep disturbance to be part of the phenotype of MPS III. Fearfulness and sleep disturbance were frequently observed in people with MPS I and II. Cognitive and motor impairment and decline, and challenging behaviour were highly prevalent in the severe form of MPS II. Cognitive decline and severe behavioural problems relating to aggression, hyperactivity, orality, unusual affect and temper tantrums were seen in MPS III. CONCLUSIONS: Sleep disturbance is part of the behavioural phenotype of MPS III, and challenging behaviour is highly prevalent in MPS II and MPS III, therefore the efficacy of behavioural interventions for these populations should be investigated. Further research into the behaviour and adaptive skills of children with MPS III and MPS IV is required.
BACKGROUND: The mucopolysaccharide disorders (MPS) are a group of recessively inherited metabolic disorders resulting in progressive physical and cognitive decline. MATERIALS AND METHODS: MEDLINE, PsycINFO and Embase databases were searched, alongside manual screening, to identify relevant literature. Papers were included in the review if they were published in a peer reviewed journal and conducted empirical research into cognitive, motor, social or linguistic development or behaviour in one or more MPS disorders. RESULTS: Twenty-five papers were reviewed. Two papers used methodology of a sufficiently high standard to demonstrate a behavioural phenotype; both found sleep disturbance to be part of the phenotype of MPS III. Fearfulness and sleep disturbance were frequently observed in people with MPS I and II. Cognitive and motor impairment and decline, and challenging behaviour were highly prevalent in the severe form of MPS II. Cognitive decline and severe behavioural problems relating to aggression, hyperactivity, orality, unusual affect and temper tantrums were seen in MPS III. CONCLUSIONS:Sleep disturbance is part of the behavioural phenotype of MPS III, and challenging behaviour is highly prevalent in MPS II and MPS III, therefore the efficacy of behavioural interventions for these populations should be investigated. Further research into the behaviour and adaptive skills of children with MPS III and MPS IV is required.
Authors: Stacey C Dusing; Deborah Thorpe; Angela Rosenberg; Vicki Mercer; Maria L Escolar Journal: Dev Med Child Neurol Date: 2006-11 Impact factor: 5.449
Authors: G J G Ruijter; M J Valstar; J M van de Kamp; R M van der Helm; S Durand; O P van Diggelen; R A Wevers; B J Poorthuis; A V Pshezhetsky; F A Wijburg Journal: Mol Genet Metab Date: 2007-11-19 Impact factor: 4.797
Authors: Ute Moog; Ingrid van Mierlo; Henny M J van Schrojenstein Lantman-de Valk; Leo Spaapen; Marian A Maaskant; Leopold M G Curfs Journal: Am J Med Genet C Semin Med Genet Date: 2007-08-15 Impact factor: 3.908
Authors: J Edmond Wraith; Maurizio Scarpa; Michael Beck; Olaf A Bodamer; Linda De Meirleir; Nathalie Guffon; Allan Meldgaard Lund; Gunilla Malm; Ans T Van der Ploeg; Jiri Zeman Journal: Eur J Pediatr Date: 2007-11-23 Impact factor: 3.183
Authors: Elaine M Cross; Sheena Grant; Simon Jones; Brian W Bigger; James E Wraith; Louise V Mahon; Michelle Lomax; Dougal J Hare Journal: J Neurodev Disord Date: 2014-12-31 Impact factor: 4.025
Authors: Cristóbal Colón; J Victor Alvarez; Cristina Castaño; Luís G Gutierrez-Solana; Ana M Marquez; María O'Callaghan; Félix Sánchez-Valverde; Carmen Yeste; María-Luz Couce Journal: Medicine (Baltimore) Date: 2017-05 Impact factor: 1.889
Authors: Arunabha Ghosh; Elsa Shapiro; Stewart Rust; Kathleen Delaney; Samantha Parker; Adam J Shaywitz; Adelaida Morte; Gillian Bubb; Maureen Cleary; Tien Bo; Christine Lavery; Brian W Bigger; Simon A Jones Journal: Orphanet J Rare Dis Date: 2017-06-26 Impact factor: 4.123
Authors: Elsa G Shapiro; Kyle Rudser; Alia Ahmed; Robert D Steiner; Kathleen A Delaney; Brianna Yund; Kelly King; Alicia Kunin-Batson; Julie Eisengart; Chester B Whitley Journal: Mol Genet Metab Rep Date: 2016-04-01